Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,106,747
+$2,488,272 QoQ
Shares Held
170,546
+195.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#670
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONECO ADVISORS, LLC holds $43,364,399 across 12 Drug Manufacturers - General names. PFE ranks #4 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
64,501 | $16,381,318 | |
| 2 | LLY |
ELI LILLY & Co
|
6,143 | $7,368,099 | |
| 3 | ABBV |
AbbVie Inc.
|
22,944 | $5,773,628 | |
| 4 | PFE |
Pfizer Inc
This page
|
170,546 | $4,106,747 | |
| 5 | GSK |
GSK plc
|
60,767 | $3,185,406 | |
| 6 | MRK |
Merck & Co., Inc.
|
18,894 | $2,427,879 | |
| 7 | AMGN |
Amgen Inc
|
4,401 | $1,593,690 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
11,852 | $682,912 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,106,747 | 170,546 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,618,475 | 57,638 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,362,204 | 54,707 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,236,264 | 48,519 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $848,496 | 35,004 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $685,066 | 27,035 | Shares | Sole | 2025-08-15 | |
| 2024-12-31 | $632,395 | 23,837 | Shares | Sole | 2025-08-15 | |
| 2024-09-30 | $687,498 | 23,756 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $854,621 | 30,544 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $871,239 | 31,396 | Shares | Sole | 2024-07-19 | |
| 2023-12-31 | $870,811 | 30,247 | Shares | Sole | 2024-03-13 | |
| 2023-09-30 | $742,510 | 22,385 | Shares | Sole | 2024-03-13 | |
| 2023-06-30 | $758,542 | 20,680 | Shares | Sole | 2024-03-13 | |
| 2023-03-31 | $857,738 | 21,023 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $922,268 | 17,999 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $769,869 | 17,593 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $918,416 | 17,517 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $747,248 | 14,434 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $862,838 | 14,612 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $591,000 | 13,741 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $524,509 | 13,394 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $461,968 | 12,751 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $482,615 | 13,111 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $395,295 | 10,771 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $303,717 | 9,288 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $289,614 | 8,873 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||